CGEM R&D Expenses
Cullinan Therapeutics Inc · R&D Expenses
CGEM R&D Expenses
Latest reported$171.47Mperiod ending
CGEM TTM R&D Expenses ($16.79M → $171.47M)
TTM R&D Expenses
High-resolution chart · PNG
CGEM r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 171,473,000 | |
| 188,066,000 | |
| 187,402,000 | |
| 184,949,000 | |
| 178,487,000 | |
| 153,716,000 | |
| 142,903,000 | |
| 137,259,000 | |
| 135,574,000 | |
| 126,706,000 | |
| 148,156,000 | |
| 134,629,000 | |
| 120,488,000 | |
| 119,508,000 | |
| 91,948,000 | |
| 91,505,000 | |
| 84,505,000 | |
| 69,872,000 | |
| 57,751,000 | |
| 53,502,000 | |
| 50,735,000 | |
| 51,453,000 | |
| 43,211,000 | |
| 30,384,000 | |
| 25,747,000 | |
| 17,106,000 | |
| 16,788,000 |